NEW YORK, NY
Flatiron Health has been awarded Frost & Sullivan’s prestigious Oncology Visionary Innovation Leadership Award for EHR and Practice Management Systems in North America. Frost & Sullivan, an independent research firm, chose Flatiron for this award for our commitment to promoting cost-effective and patient-centric coordinated care.
Frost & Sullivan identifies Flatiron’s OncoCloud™ suite as the nation’s best-in-class oncology software platform, helping oncology practices transition to value-based clinical and business strategies through greater system connectivity and deeper analytical insights. Through our flagship OncoEMR® product, Flatiron facilitates the transition to value-based care, including programs like the Merit-based Incentive Payment System and the Oncology Care Model. Our analytics solutions also provide up-to-date, robust, and reliable data to drive proper and timely clinical, operational, and financial decisions.
“Through Flatiron’s oncology-specific software platform, the company offers a secure, scalable, leading oncology health IT solution, promoting cost-effective, patient-centric and coordinated cancer care.” said Frost & Sullivan Research Analyst Koustav Chatterjee. “Flatiron’s evidence-based approach aligns with today’s value-driven healthcare landscape. Through its integrated oncology-specific software-as-a-service platform, the company steadily bridges the clinical practice and research gap to deliver better treatment options for improved patient outcomes.”
“It’s an honor to be recognized by Frost & Sullivan for the products and services that we have developed alongside our community oncology network,” said Brenton Fargnoli, MD, Flatiron Health’s medical director of value-based care and director of product marketing and strategy. “We know that community oncology is incredibly complex and we are laser focused on building the technology platform that providers need to succeed in the ever-changing landscape.”
Flatiron’s OncoCloud suite is built to meet the technology needs of the community oncology practice of the future: operationally efficient and prepared to thrive in a world driven by value-based care. For more information about our products and services, click here.
About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group.
